Melissa has a background in early phase bioequivalence clinical trials and in late phase Neurology clinical trials, specifically Alzheimer's disease . 

She holds a BSc in Health Sciences and a Diploma in Clinical Trials Management, both from Western University. 
Why RetiSpec?
At RetiSpec,I gain invaluable experience working alongside a team that is pushing boundaries and moving Alzheimer's biomarker science forward. Our work is trailblazing, and will positively impact the lives of so many. 

• 

  Clinical Project Specialist in RetiSpec

  Point of care and AI-driven early detection of Alzheimer’s, through a simple eye exam.